首页|甲状腺癌组织HSP70表达与临床病理特征及术后复发的关联性分析

甲状腺癌组织HSP70表达与临床病理特征及术后复发的关联性分析

扫码查看
目的:探讨甲状腺癌组织热休克蛋白70(HSP70)表达与临床病理特征及术后复发的关系.方法:回顾性分析2018 年6月—2019 年12 月某院行手术治疗的165 例甲状腺癌患者的临床资料,术中提取研究对象的癌组织和癌旁正常组织标本,采用免疫组化法检测甲状腺癌组织和癌旁正常组织HSP70 表达水平,分析不同临床病理特征的甲状腺癌患者癌组织HSP70 表达,采用单因素和多因素Logistic回归分析影响甲状腺癌术后复发的影响因素.结果:甲状腺癌组织中HSP70 表达水平(0.87±0.23)高于癌旁正常组织(0.41±0.07),差异有统计学意义(P<0.001).肿瘤最大直径≤4 cm、病理类型为分化型、TNM分期为Ⅰ~Ⅱ期的甲状腺癌患者癌组织中HSP70 表达水平分别为(0.83±0.23)、(0.72±0.19)、(0.69±0.15),低于肿瘤最大直径>4 cm、病理类型为非分化型、TNM分期Ⅲ~Ⅳ期患者癌组织的(0.95±0.27)、(1.39±0.32)、(1.02±0.28),有淋巴结转移的甲状腺癌患者癌组织中HSP70 表达水平为(0.99±0.26),高于无淋巴结转移患者癌组织的(0.75±0.21),差异有统计学意义(P<0.05).甲状腺癌患者术后3 年复发率为23.64%.多因素Logistic回归分析结果显示,肿瘤最大直径>4 cm、病理类型为非分化型、TNM分期为Ⅲ~Ⅳ期、有淋巴结转移、甲状腺癌组织HSP70 表达升高是甲状腺癌术后复发的独立危险因素.结论:甲状腺癌组织中HSP70 呈高表达,甲状腺癌组织中HSP70 高表达、肿瘤最大直径>4 cm、病理类型为非分化型、TNM分期Ⅲ~Ⅳ期、有淋巴结转移均是甲状腺癌术后复发的独立危险因素.
Exploration of relationship between HSP70 expression in thyroid cancer tissue and clinical pathological characteristics and postoperative recurrence
Objective:To investigate the relationship between the expression of heat shock protein 70(HSP70)in thyroid cancer tissue and clinical pathological characteristics and postoperative recurrence.Methods:A retrospective analysis was conducted on the clinical data of 165 patients with thyroid cancer who underwent surgical treatment in a hospital from June 2018 to December 2019.The expressions of HSP70 in thyroid cancer tissue and adjacent normal tissues were detected using immunohistochemical methods.The ex-pressions of HSP70 in thyroid cancer tissues with different clinical pathological characteristics were compared.The influencing factors of postoperative recurrence in thyroid cancer were analyzed using univariate and multivariate Logistic regression analysis.Results:The ex-pression of HSP70 in thyroid cancer tissue(0.87±0.23)was higher than that in adjacent normal tissue(0.41±0.07),and the difference was statistically significant(P<0.001).The expressions of HSP70 in thyroid cancer tissues of patients with maximum tumor diameter>4cm,non-differentiated,TNM stages Ⅲ~Ⅳ,and lymph node metastasis(0.95±0.27,1.39±0.32,1.02±0.28,0.99±0.26)were higher than those of patients with maximum tumor diameter≤4cm,differentiated,TNM stages Ⅰ~Ⅱ,and no lymph node metastasis(0.83±0.23,0.72±0.19,0.69±0.15,0.75±0.21),the differences being statistically significant(P<0.05).The 3-year recurrence rate of thyroid cancer patients after surgery was23.64%(39/165).The results of multivariate Logistic regression a-nalysis showed that maximum tumor diameter>4cm(95%CI:1.311~5.130,P=0.006),non-differentiated(95%CI:1.895~7.500,P<0.001),TNM stage Ⅲ~Ⅳ(95%CI:1.567~6.105,P=0.001),lymph node metastasis(95%CI:1.205~4.226,P=0.013),and elevated HSP70 expression(95%CI:1.568~7.976,P=0.002)in thyroid cancer tissue were independent risk factors for postoperative recurrence of thyroid cancer(P<0.05).Conclusion:HSP70 is highly expressed in thyroid cancer tissue,which is related to tumor size,pathological type,TNM staging,lymph node metastasis and postoperative recurrence,and high expression of HSP70 in thyroid cancer tissue,maximum tumor diameter>4cm,non-differentiated,TNM stage Ⅲ~Ⅳ,and lymph node metastasis are inde-pendent risk factors for postoperative recurrence of thyroid cancer.

Thyroid cancerHeat shock protein 70Clinical pathological characteristicsPostoperative recurrence

张修志、翟慧萍、魏哲

展开 >

河南省新乡市第二人民医院 功检科,453000

甲状腺肿瘤 热休克蛋白70 病理特征 术后复发

2024

淮海医药
蚌埠市医学科学情报站 《淮海医药》编辑部

淮海医药

影响因子:0.58
ISSN:1008-7044
年,卷(期):2024.42(4)